Structural Analysis of Leukotriene B4 (LBT4) Receptor (BLT1 AND BLT2) Antagonists
暂无分享,去创建一个
[1] M. Tanimoto,et al. Blocking the leukotriene B4 receptor 1 inhibits late-phase airway responses in established disease. , 2011, American journal of respiratory cell and molecular biology.
[2] D. Šatínský,et al. Antileukotrienic phenethylamido derivatives of arylalkanoic acids in the treatment of ulcerative colitis. , 2009, European journal of medicinal chemistry.
[3] D. Hadjipavlou-Litina,et al. Lipoxygenase inhibitors: A comparative QSAR study review and evaluation of new QSARs , 2008, Medicinal research reviews.
[4] P. Renard,et al. Synthesis and Structure−Activity Relationships of New 1,3-Disubstituted Cyclohexanes as Structurally Rigid Leukotriene B4 Receptor Antagonists , 1999 .
[5] R. Fujimoto,et al. Carboxy-substituted cinnamides: a novel series of potent, orally active LTB4 receptor antagonists. , 1999, Journal of Medicinal Chemistry.
[6] F. Marks,et al. Prostaglandins, leukotrienes, and other eicosanoids : from biogenesis to clinical applications , 1999 .
[7] B. Dominy,et al. trans-3-Benzyl-4-hydroxy-7-chromanylbenzoic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptor. , 1998, Bioorganic & medicinal chemistry letters.
[8] E. Laird,et al. 3-Substituted-4-hydroxy-7-chromanylacetic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptor , 1997 .
[9] K. Moriarty,et al. A novel series of [2-[methyl(2-phenethyl)amino]-2-oxoethyl] benzene-containing leukotriene B4 antagonists: initial structure-activity relationships. , 1996, Journal of Medicinal Chemistry.
[10] K. Moriarty,et al. Structure-activity relationships study of two series of leukotriene B4 antagonists: novel indolyl and naphthyl compounds substituted with a 2-[methyl(2-phenethyl)amino]-2-oxoethyl side chain. , 1996, Journal of Medicinal Chemistry.
[11] J. Summers,et al. Modulators of leukotriene biosynthesis and receptor activation. , 1996, Journal of medicinal chemistry.
[12] W. Jackson,et al. Synthetic and structure/activity studies on acid-substituted 2-arylphenols: discovery of 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]-propoxy]phenoxy]benzoic acid, a high-affinity leukotriene B4 receptor antagonist. , 1995, Journal of medicinal chemistry.
[13] A. Marfat,et al. Synthesis and in vitro profile of 7-substituted quinoline chromanols as novel, non-acidic LTB4 antagonists , 1995 .
[14] J. Snyder,et al. Second-generation leukotriene B4 receptor antagonists related to SC-41930: heterocyclic replacement of the methyl ketone pharmacophore. , 1995, Journal of Medicinal Chemistry.
[15] A. Milici,et al. (+)-1-(3S,4R)-[3-(4-phenylbenzyl)-4-hydroxychroman-7-yl]cyclopentane carboxylic acid, a highly potent, selective leukotriene B4 antagonist with oral activity in the murine collagen-induced arthritis model. , 1994, Journal of medicinal chemistry.
[16] T. Rao,et al. Synthesis and pharmacological activity of SC-53228, a leukotriene B4 receptor antagonist with high intrinsic potency and selectivity , 1994 .
[17] H. Sarau,et al. (E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid: a novel high-affinity leukotriene B4 receptor antagonist. , 1993, Journal of Medicinal Chemistry.
[18] W. Jackson,et al. -alkoxyphenol leukotriene B4 receptor antagonists: effect of a chroman carboxylic acid. , 1992 .
[19] K. Moriarty,et al. 4-[2-[Methyl(2-phenethyl)amino]-2-oxoethyl]-8-(phenylmethoxy)-2- naphthalenecarboxylic acid: a high affinity, competitive, orally active leukotriene B4 receptor antagonist. , 1992, Journal of medicinal chemistry.
[20] J. Musser,et al. 5-lipoxygenase: properties, pharmacology, and the quinolinyl(bridged)aryl class of inhibitors. , 1992, Journal of medicinal chemistry.
[21] G. Butchko,et al. 7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]-3,4-dihydro-8- propyl-2H-1-benzopyran-2-carboxylic acid: an orally active selective leukotriene B4 receptor antagonist. , 1989, Journal of medicinal chemistry.
[22] F. Baker,et al. 2,3-Dihydro-5-benzofuranols as antioxidant-based inhibitors of leukotriene biosynthesis. , 1989, Journal of medicinal chemistry.